Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Article
  • Published:

Session III – Homologous Replacement/Gene Targeting

Application of SFHR to gene therapy of monogenic disorders

Gene Therapy volume 9, pages 691–694 (2002)Cite this article

Abstract

Gene therapy treatment of disease will be greatly facilitated by the identification of genetic mutations through the Human Genome Project. The specific treatment will ultimately depend on the type of mutation as different genetic lesions will require different gene therapies. For example, large rearrangements and translocations may call for complementation with vectors containing the cDNA for the wild-type (wt) gene. On the other hand, smaller lesions, such as the reversion, addition or deletion of only a few base pairs, on single genes, or monogenic disorders, lend themselves to gene targeting. The potential for one gene targeting technique, small fragment homologous replacement (SFHR) to the gene therapy treatment of sickle cell disease (SCD) is presented. Successful conversion of the wt-β-globin locus to a SCD genotype of human lymphocytes (K562) and progenitor/stem hematopoietic cells (CD34+ and lin-CD38−) was achieved by electroporation or microinjection small DNA fragments (SDF).

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Colosimo A et al. Targeted correction of a defective selectable marker gene in human epithelial cells by small DNA fragments Mol Ther 2001 3: 178–185

    Article  CAS  PubMed  Google Scholar 

  2. Thorpe P, Stevenson B, Gohil A, Porteous D . Towards CFTR gene correction: a comparison of two key strategies Ped Pulmon 2000 241

  3. Kapsa R et al. In vivo and in vitro correction of the mdx dystrophin gene nonsense mutation by short-fragment homologous replacement Hum Gene Ther 2001 12: 629–642

    Article  CAS  PubMed  Google Scholar 

  4. Goncz K, Kunzelmann K, Xu Z, Gruenert D . Targeted replacement of normal and mutant CFTR sequences in human airway epithelial cells using DNA fragments Hum Mol Genet 1998 7: 1913–1919

    Article  CAS  PubMed  Google Scholar 

  5. Kunzelmann K et al. Gene targeting of CFTR DNA in CF epithelial cells Gene Therapy 1996 3: 859–867

    CAS  PubMed  Google Scholar 

  6. Sangiuolo F et al. In vitro correction of CF cells using SFHR technique Pediatric Pulmonary 2000 240

  7. Goncz K et al. Expression of DeltaF508 CFTR in normal mouse lung after site-specific modification of CFTR sequences by SFHR Gene Therapy 2001 8: 961–965

    Article  CAS  PubMed  Google Scholar 

  8. Goncz K . Conversion of normal β-globin to sickle β-globin by small fragment homologous replacement Blood 2000 96: 379b

    Google Scholar 

  9. Mookerjee B, Arcasoy M, Atweh G . Spontaneous delta- to beta-globin switching in K562 human leukemia cells Blood 1992 79: 820–825

    CAS  PubMed  Google Scholar 

  10. Mahajan M, Weissman S . DNA-dependent adenosine triphosphatase (helicase-like transcription factor) activates beta-globin transcription in K562 cells Blood 2002 99: 348–356

    Article  CAS  PubMed  Google Scholar 

  11. Goncz K, Gruenert D . Progress toward nucleotide sequence modification at the genome level: small fragment homologous replacement Biotechnology 2001 3: 113–120

    Google Scholar 

  12. Xiang Y et al. Targeted gene conversion in a mammalian CD34+ enriched cell population using chimeric RNA/DNA oligonucleotides J Mol Med 1997 75: 829–835

    Article  CAS  PubMed  Google Scholar 

  13. Holmes A et al. Intracellular compartmentalization of DNA fragments in cultured airway epithelial cells mediated by cationic lipids Pharm Res 1999 16: 1020–1025

    Article  CAS  PubMed  Google Scholar 

  14. Kasahara N, Dozy A, Kan YW . Tissue-specific targeting of retroviral vectors through ligand-receptor interactions Science 1994 266: 1373–1376

    Article  CAS  PubMed  Google Scholar 

  15. Takekoshi KJ et al. Retroviral transfer of a human beta-globin/delta-globin hybrid gene linked to beta locus control region hypersensitive site 2 aimed at the gene therapy of sickle cell disease Proc Natl Acad Sci USA 1995 92: 3014–3018

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Miyoshi H et al. Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors Science 1999 283: 682–686

    Article  CAS  PubMed  Google Scholar 

  17. Naldini L, Verma IM . Lentiviral vectors Adv Virus Res 2000 55: 599–609

    Article  CAS  PubMed  Google Scholar 

  18. Hirata R, Miller A, Andrews R, Russell D . Transduction of hematopoietic cells by foamy virus vectors Blood 1996 88: 3654–3661

    CAS  PubMed  Google Scholar 

  19. Einerhand MP et al. Regulated high-level human beta-globin gene expression in erythroid cells following recombinant adeno-associated virus-mediated gene transfer Gene Therapy 1995 2: 336–343

    CAS  PubMed  Google Scholar 

  20. Lubovy M et al. Stable transduction of recombinant adeno-associated virus into hematopoietic stem cells from normal and sickle cell patients Biol Blood Marrow Transplant 1996 2: 24–30

    CAS  PubMed  Google Scholar 

  21. Fritsch G et al. The composition of CD34 subpopulations differs between marrow, blood and cord blood Bone Marrow Transplant 1996 17: 169–178

    CAS  PubMed  Google Scholar 

  22. Wang J, Doedens M, Dick J . Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell assay Blood 1997 89: 3919–3924

    CAS  PubMed  Google Scholar 

  23. Colosimo A et al. Simple version of ‘megaprimer’ PCR for site-directed mutagenesis BioTechniques 1999 26: 870–873

    Article  CAS  PubMed  Google Scholar 

  24. Davis B et al. Glass needle-mediated microinjection of macromolecules and transgenes into primary human blood stem/progenitor cells Blood 2000 95: 437–444

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Human Molecular Genetics Unit, University of Vermont, Burlington, VT, USA

    K K Goncz & D C Gruenert

  2. Gene-Cell, Inc., Houston, TX, USA

    N L Prokopishyn, B L Chow & B R Davis

Authors
  1. K K Goncz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N L Prokopishyn
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B L Chow
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. B R Davis
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D C Gruenert
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Goncz, K., Prokopishyn, N., Chow, B. et al. Application of SFHR to gene therapy of monogenic disorders. Gene Ther 9, 691–694 (2002). https://doi.org/10.1038/sj.gt.3301743

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3301743

Keywords

This article is cited by

Search

Advanced search

Quick links